Welcome : Guest

ANI Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ANI Pharmaceuticals, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 71 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63734
Price: $3500
Company Type: Public
Pages: 74
Date: November 2016
Market Data Tables: 71

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: ANI Pharmaceuticals, Inc.’s Sales by Business Segment (2014-2015) in Percentage for Generic Pharmaceutical Products, Branded Pharmaceutical Products, Contract Manufacturing, and Contract Service and Other Income......3
Table 2: ANI Pharmaceuticals, Inc.'s Sales by Business Segment (2013-2014) in Percentage for Generic Pharmaceutical Products, Branded Pharmaceutical Products, Contract Manufacturing and Contract Services and Other Income......4
Generic Drugs......6
Table 3: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World......6
Table 4: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......7
Narcotic Drugs......8
Table 5: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......8
Table 6: Narcotic Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Morphine, Oxycodone, Tramadol and Others......9
Anti-Cancer Drugs......10
Table 7: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......10
Table 8: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......11
Gastrointestinal Drugs......12
Table 9: Gastrointestinal Market Worldwide (2015) in US$ Million......12
Table 10: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......13
Gastroesophageal Reflux Disease (GERD) Drugs......14
Table 11: Gastroesophageal Reflux Disease (GERD) Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Aciphex, Dexiant, Lansporazole, Nexium, Omeprazole, and Others......14
Anti-Osteoarthritis......15
Table 12: Anti-Osteoarthritis Market in Korea (2015-2020) in KRW Million......15
Rheumatoid Arthritis......16
Table 13: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......16
Chronic Pain......17
Table 14: No. of Population with Chronic Pain by Age in the US (2015) - Percentage Share Breakdown by Volume for 18 & over and 18 & Under......17
Table 15: No. of Population with Chronic Pain by Type in the US (2015) - Percentage Breakdown by Volume for Back Pain and Other Pain......18
Table 16: Chronic Pain in Adults by Pain Type in the US (2015) - Percentage Share Breakdown by Volume for Knee Pain, Low Back Pain, Serve Headache or Migraine......19
Table 17: No. of People with Chronic Pain in the US (2015-2020) in Million......20
Spinal Cord Stimulation (SCS) for Chronic Pain......21
Table 18: Spinal Cord Stimulation Systems for Chronic Pain (incl. back pain, leg pain and back/leg pain) Market Worldwide (2015) in US$ Million......21
Table 19: Spinal Cord Stimulation (SCS) for Chronic Pain by Category in the US (2015) - Percentage Share Breakdown by Volume for Back Pain alone, Leg & Back Pain, Leg Pain alone and Upper Extremity Pain......22
Glaucoma Disease......23
Table 20: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......23
Table 21: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......24
Table 22: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......25
Glaucoma Drugs......26
Table 23: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......26
Table 24: Blindness Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Age-Related Macular Degeneration, Cataract, Glaucoma, and Others......27
Extended-Release Opioid......28
Table 25: Extended-Release Opioid Market by Payment Method in the US (2015) - Percentage Share Breakdown by Value for Cash, Commercial, Managed Medicaid, Medicaid and Medicare......28
Hormone Therapy......29
Table 26: Hormone Therapy Treatment Market by Specialist Type Worldwide (2015) - Percentage Share Breakdown by Value for Oncologists, Urologists and Others......29
Table 27: Female Hormone Treatment Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Hormone Replacement Therapy and Others......30
Table 28: Female Hormone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Estrogen, Hormone Replacement Therapy and Vegetable Female Hormone......31
Table 29: Female Hormone Treatment Market by Product in Korea (2015) - Percentage Share Breakdown by Value for Natural Estrogen Therapy and Others......32
Contraceptives......33
Table 30: Contraceptives Usage by Method Worldwide (2015) - Percentage Share Breakdown by Value for Condom, Female Sterilization, Intrauterine Device, Pill, Traditional, and Others......33
Hormonal Contraceptive......34
Table 31: Hormonal Contraceptive Market by Category in the US (2015) - Percentage Share Breakdown by Value for Combination Hormonal Tablets, Injectable and Implant, Nuvaring, and Patch......34
Hypertension Treatment......35
Table 32: Hypertension Treatment Market by Segment in China (2015) - Percentage Share Breakdown by Value for Products to Regulate Blood Lipid Levels, and Products to Regulate Blood Sugar......35
Menopausal Symptoms......36
Table 33: Menopausal Symptoms Distribution by Age Group in Korea (2015) - Percentage Share Breakdown by Volume for Age 45 - 49, Age 50-54, Age 55- 59 and Others......36
Premenopausal Female Sexual Dysfunction......37
Table 34: Premenopausal Female Sexual Dysfunction Population by Age Group in the US (2015) - Percentage Share Breakdown for 20 - 30 Year Old, 30 - 40 Year Old, and 40 - 50 Year Old......37
Testosterone Replacement Therapy (TRT)......38
Table 35: Testosterone Replacement Therapy Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for ANDROGEL, AXIRON, INJECTABLES, TESTIM and Others......38
Table 36: Testosterone Replacement Therapy (TRT) Market by Type in the UK (2015) - Percentage Share Breakdown by Value for Capsules, Gels, Injections, and Patches......39
Table 37: Testosterone Replacement Therapy Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectables and Topicals......40
Women's Health Drugs......41
Table 38: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......41
Generic Pharmaceuticals......42
Table 39: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......42
Table 40: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Others......43
Table 41: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......44
Table 42: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......45
Table 43: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......46
Table 44: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......47
Table 45: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......48
Table 46: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......49
Table 47: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. and GlaxoSmithKline......50
Table 48: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......51
Table 49: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......52
Table 50: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......53
Table 51: Market Shares of Leading Narcotic Drugs Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Beijing Mundipharma Ltd., China National Medicines Corporation, Impofstoffwerk Dessau Tomau GmbH, Notheast Pharmaceutical Group ., Ltd., Shanhaiguan Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., The Grunenthal Group, Weihal Lotus Pharmaceutical Co., Ltd., Wuhan HumanWell Bi-Tech Industry Co., Ltd., Xian-Janseen Pharmaceutical Ltd., and Others......54
Anti-Osteoarthritis Medicine......55
Table 52: Market Shares of Leading Anti-Osteoarthritis Medicine Manufacturers in Korea (2015) - Percentage Breakdown by Value for Humedix Co., Ltd., and Others......55
Clostridium Difficile-Associated Diarrhea (CDAD)......56
Table 53: Market Shares of Leading Drugs for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in the US (2015) - Percentage Share Breakdown by Value for METRONIDAZOLE INJECTION, METRONIDAZOLE Oral, VANCOMYCIN Oral Solution and Others......56
Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics......57
Table 54: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......57
Table 55: MRSA Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Semi-Synthetics/SYNERCID, Tygacil, Vancomycin, Zyvox IV, and Zyvox Oral......58
Metoclopramide......59
Table 56: Market Shares of Leading Metoclopriamide Brands for Gastroparesis in the US (2015) - Percentage Share Breakdown by Value for Metozolv, and Reglan......59
Opioids......60
Table 57: Market Shares of Leading Opioids Brands Worldwide (2015) - Percentage Share Breakdown by Value for Codeine, Hydrocodone, Oxycodone and Others......60
Steroids......61
Table 58: Steroids Market by Nasal Drug in the UK (2015) - Percentage Share Breakdown by Value for Flonase/Flutic Asone, Nasacort, Nasonex, Omnaris, Rhinocort and Veramyst......61
Skin Infection......62
Table 59: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......62
Table 60: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......63
Table 61: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......64
Table 62: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......65
Table 63: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......66
Table 64: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......67
Anti-Diarrhea Tablet......68
Table 65: Market Shares of Leading Diarrhea Remedies (Tablet) Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Imodium A-D, Private Label, and Others......68
Table 66: Market Shares of Leading Anti-Diarrhea Tablet Brands through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Imodium, Imodium A-D, Private label, and Others......69
Female Hormone Drugs......70
Table 67: Market Shares of Leading Female Hormone Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Naturalendo, Novo Nordisk, Pfizer, Inc., Warner Chilcott and Others......70
Contraceptive Products......71
Table 68: Market Shares of Leading Contraceptive Product Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Church & Dwight Co., Inc., and Others......71
Table 69: Market Shares of Leading Contraceptive Products Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Church & Dwight Co., Inc., and Others......72
Female Contraceptive Product......73
Table 70: Market Shares of Leading Female Contraceptive Product Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Teva Women's Health, Inc., Watson Pharmaceuticals, Inc., Private Label, and Others......73
Table 71: ANI Pharmaceuticals Inc.'s Pharmaceutical Sales by Category (2015) - Percentage Share Breakdown by Value for Branded and Generic......74